share_log

Ginkgo Bioworks | 4: Statement of changes in beneficial ownership of securities-Director HENRY CHRISTIAN O

Ginkgo Bioworks | 4: Statement of changes in beneficial ownership of securities-Director HENRY CHRISTIAN O

Ginkgo Bioworks | 4:持股變動聲明-董事 HENRY CHRISTIAN O
美股sec公告 ·  06/15 04:38
牛牛AI助理已提取核心訊息
Christian O. Henry, associated with Ginkgo Bioworks Holdings, Inc. [DNA], executed a transaction on June 12, 2024, involving the acquisition of 105,263 shares of Class A Common Stock. The transaction, coded as 'M' indicating an exercise or conversion of derivative security, resulted in Henry's direct ownership of 1,339,641 shares post-transaction. The action reflects a significant investment in the company's stock, with the acquired shares adding to Henry's already substantial stake in Ginkgo Bioworks.
Christian O. Henry, associated with Ginkgo Bioworks Holdings, Inc. [DNA], executed a transaction on June 12, 2024, involving the acquisition of 105,263 shares of Class A Common Stock. The transaction, coded as 'M' indicating an exercise or conversion of derivative security, resulted in Henry's direct ownership of 1,339,641 shares post-transaction. The action reflects a significant investment in the company's stock, with the acquired shares adding to Henry's already substantial stake in Ginkgo Bioworks.
基督教·O·亨利與銀杏生物科技控股有限公司[Ginkgo Bioworks Holdings, Inc.][DNA]相關,於2024年6月12日執行了一項交易,涉及收購105,263股A類普通股。該交易被編碼爲“M”,表示衍生證券的行權或轉換,導致亨利在交易後直接擁有1,339,641股股份。此舉反映了對公司股票的重要投資,收購的股票增加了亨利在銀杏生物科技中已經廣泛持有的股份。
基督教·O·亨利與銀杏生物科技控股有限公司[Ginkgo Bioworks Holdings, Inc.][DNA]相關,於2024年6月12日執行了一項交易,涉及收購105,263股A類普通股。該交易被編碼爲“M”,表示衍生證券的行權或轉換,導致亨利在交易後直接擁有1,339,641股股份。此舉反映了對公司股票的重要投資,收購的股票增加了亨利在銀杏生物科技中已經廣泛持有的股份。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。